LLY Stock Down on Lower-Than-Expected Sales Guidance for Q4

LLY Stock Down On Lower-Than-Expected Sales Guidance For Q4

3 weeks from now

Jan 15, 2025  · LLY's shares slip more than 6% as it cuts outlook for 2024 sales. Preliminary fourth-quarter revenues fall short of estimates. LLY Stock Down on Lower-Than-Expected …

nasdaq.com

Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion …

3 weeks from now

Jan 14, 2025  · Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion Sales From Weight Loss/Diabetes Drugs, Stock Tanks ... in addition to lower-than-expected channel …

yahoo.com

Eli Lilly Stock Tumbles After New Forecasts Show Weight-loss Drug …

3 weeks from now

Jan 14, 2025  · Eli Lilly (LLY) shares traded down more than 6% Tuesday after the company reported revenue guidance for the fourth quarter of 2024 that missed Wall Street expectations. …

yahoo.com

LLY Stock Down On Lower-Than-Expected Sales Guidance For Q4

3 weeks from now

Jan 15, 2025  · Eli Lilly and Company’s LLY shares declined 6.6% on Tuesday after the company lowered its sales guidance for full-year 2024 and announced disappointing preliminary fourth …

tradingview.com

Eli Lilly Stock Slumps On Lowered Sales Forecast - Investopedia

3 weeks from now

Jan 14, 2025  · The maker of weight-loss drugs Mounjaro and Zepbound said sales grew slower than expected in the fourth quarter. ... lower than the $45.4 billion to $46 ... Eli Lilly shares …

investopedia.com

Lilly Provides Update On 2024 Revenue Guidance, Announces 2025 …

3 weeks from now

Jan 14, 2025  · 2024 revenue is expected to be approximately $45.0 billion for the full year, $4.0 billion above the midpoint of first-time 2024 financial guidance. Q4 2024 revenue is expected …

lilly.com

Why Eli Lilly (LLY) Stock Is Declining Today - Yahoo Finance

3 weeks from now

Jan 14, 2025  · The shares of pharmaceutical giant Eli Lilly (LLY) are falling 5% today after the company preannounced lower-than-expected fourth-quarter revenue. The firm estimated that it …

yahoo.com

Here’s Why Eli Lilly Stock Is Crashing - Finbold

3 weeks from now

Jan 15, 2025  · Eli Lilly (NYSE: LLY) saw its stock decline sharply by 6.5% on January 14, following the release of its fourth-quarter 2024 revenue guidance, which fell short of Wall …

finbold.com

Eli Lilly Stock Falls On Lower Q4 Sales Guidance - LLY Stock

3 weeks from now

Jan 16, 2025  · Eli Lilly and Company’s (LLY) shares dropped 6.6% following the release of disappointing fourth-quarter sales and a reduced revenue outlook for 2024. The company’s …

investingsnacks.com

Eli Lilly Falls More Than 10% In A Month: Buy, Sell Or Hold The Stock?

3 weeks from now

Nov 11, 2024  · Several phase III data readouts are expected in 2025. LLY’s Stock, Valuation and Estimates. Lilly’s stock has risen 42.7% so far this year compared with an increase of 11.6% …

nasdaq.com

Why Eli Lilly (LLY) Stock Is Declining Today - Insider Monkey

3 weeks from now

Jan 14, 2025  · The shares of pharmaceutical giant Eli Lilly (LLY) are falling 5% today after the company preannounced lower-than-expected fourth-quarter revenue. The firm estimated that it …

insidermonkey.com

Lilly Stock Drops 7% As 2024 Revenue Projection Falls Short Of …

3 weeks from now

Jan 14, 2025  · After the pharmaceutical behemoth said that its fourth-quarter 2024 sales prediction of $13.5 billion missed earlier guidance by $400 million, Eli Lilly and Company (LLY, …

tradingview.com

Eli Lilly Missed Sales Expectations Again. Should Investors Be …

3 weeks from now

Jan 19, 2025  · The stock peaked last October and was down by more than 21% when the market closed on Jan. 16. ... At the midpoint of management's guidance range, top-line sales are …

fool.com

Why Is Lilly (LLY) Down 5% Since Last Earnings Report?

3 weeks from now

Nov 29, 2024  · Lilly’s third-quarter results were weaker than expected as it missed estimates for earnings and sales and also lowered its financial guidance for the year. Lilly reported third …

nasdaq.com

LLY Stock Down On Lower-Than-Expected Sales Guidance For Q4

3 weeks from now

Jan 15, 2025  · Eli Lilly and Company’s (LLY Quick Quote LLY - Free Report) shares declined 6.6% on Tuesday after the company lowered its sales guidance for full-year 2024 and …

zacks.com

Why Is Lilly (LLY) Down 5% Since Last Earnings Report? - Yahoo …

3 weeks from now

Nov 29, 2024  · Lilly’s third-quarter results were weaker than expected as it missed estimates for earnings and sales and also lowered its financial guidance for the year. Lilly reported third …

yahoo.com

Eli Lilly Shares Fall After GLP-1 Sales Miss Expectations. Is The Stock ...

3 weeks from now

Jan 23, 2025  · The good news for investors is that for 2025, overall guidance is looking strong. Lilly is projecting between $58 billion and $61 billion in sales, which is mostly higher than the …

fool.com

Eli Lilly (LLY) Stock Drops Despite Market Gains: Important Facts To ...

3 weeks from now

4 days ago  · Eli Lilly (LLY Quick Quote LLY - Free Report) closed the latest trading day at $804.99, indicating a -0.39% change from the previous session's end.The stock trailed the …

zacks.com

Eli Lilly (LLY) Earnings Expected To Grow: What To Know Ahead Of …

3 weeks from now

1 day ago  · This drugmaker is expected to post quarterly earnings of $5.15 per share in its upcoming report, which represents a year-over-year change of +106.8%. Revenues are …

yahoo.com

LLY Stock Down On Lower-Than-Expected Sales Guidance For Q4

3 weeks from now

LLY’s 2025 Revenue Guidance In Line With Expectations. In 2025, Lilly expects to record revenues in the range of $58.0 billion to $61.0 billion, indicating growth of 32% at the midpoint …

msn.com